Giovanni Germano
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Pharmacologic Inhibition of PMS2 Induces MMR Deficiency and Response to Immune Checkpoint Blockade.
Journal: Cancer discovery
Published: January 04, 2026
A subset of MMR-proficient colon cancers responds to neoadjuvant immunotherapy.
Journal: Molecular oncology
Published: November 18, 2025
Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in Cancer.
Journal: Cancer research
Published: May 28, 2025
DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors.
Journal: British journal of cancer
Published: April 16, 2024
Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models.
Journal: Cancer cell
Published: April 25, 2023
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors.
Journal: Nature communications
Published: March 29, 2023
Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer.
Journal: Genome medicine
Published: September 14, 2022
Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 12, 2022
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.
Journal: Cancer discovery
Published: November 01, 2021
Last Updated: 09/26/2026